Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The Journal of Pathology|September 27, 2024
TERT upregulation promotes cell proliferation via degradation of p21 and increases carcinogenic potentialMasako Mishima, Atsushi Takai, Haruhiko Takeda, et al.Scientific Reports|April 30, 2022
Mutational spectrum of hepatitis C virus in patients with chronic hepatitis C determined by single molecule real-time sequencingFumiyasu Nakamura, Haruhiko Takeda, Yoshihide Ueda, et al.Carcinogenesis|February 22, 2021
Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virusHaruhiko Takeda, Atsushi Takai, Eriko Iguchi, et al.The Oncologist|June 13, 2019
Association Between Preanalytical Factors and Tumor Mutational Burden Estimated by Next-Generation Sequencing-Based Multiplex Gene Panel AssayPham Nguyen Quy, Masashi Kanai, Keita Fukuyama, et al.Cancer Research|April 1, 2022
Expansion of Gastric Intestinal Metaplasia with Copy Number Aberrations Contributes to Field CancerizationKen Kumagai, Takahiro Shimizu, Atsushi Takai, et al.Journal of Gastroenterology|September 17, 2024
CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective studyMasayuki Ueno, Haruhiko Takeda, Atsushi Takai, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 13, 2025
Lenvatinib Versus Atezolizumab Plus Bevacizumab as First-Line Treatment for Advanced Hepatocellular Carcinoma With a CRAFITY Score of 2: A Multi-Center Retrospective StudyMasayuki Ueno, Haruhiko Takeda, Atsushi Takai, et al.Journal of Gastroenterology|June 13, 2023
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitisHiroyuki Yoshida, Masahiro Shiokawa, Takeshi Kuwada, et al.Pageof 5